Genedata and ChemAxon Integrate Lead Discovery Technologies
News Jan 16, 2007
The integrated solution can capture and display discovery relevant information to help researchers identify drug candidates.
Scientific computing specialists at Genedata and ChemAxon have integrated the chemical intelligence functionality of MarvinView with Hit Profiler, Genedata’s software solution for the prioritization of hits to leads.
MarvinView is a platform-independent interactive visualization tool for viewing and managing chemical structure information.
The success of the integration rests on the fact that both companies use the same advanced software technologies, including Java 5 generics and concurrency APIs.
“Our customers recognize the value of integrated technologies for solving their business problems”, explained Dr. Stephan Heyse, Head of Genedata Screener.
Tuberculosis (TB), an ancient and notoriously difficult disease to treat, has killed millions through the course of human history; and the antibiotics that have been used to fight the disease in recent history are becoming less and less effective. In the face of this reality, researcher Prof. Dennis Wright has improved upon a new way to thwart the tricky pathogen, mycobacterium tuberculosis.READ MORE
Researchers have solved the structures of the cancer-promoting enzymes USP25 and USP28, and identified significant differences in their activities. This knowledge provides the molecular basis for the development of new and highly specific anti-cancer drugs, with a low risk of side-effects.READ MORE